GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cel AI PLC (LSE:CLAI) » Definitions » Current Deferred Revenue

Cel AI (LSE:CLAI) Current Deferred Revenue : £0.00 Mil (As of Aug. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Cel AI Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Cel AI's current deferred revenue for the quarter that ended in Aug. 2023 was £0.00 Mil.

Cel AI Current Deferred Revenue Historical Data

The historical data trend for Cel AI's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cel AI Current Deferred Revenue Chart

Cel AI Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23
Current Deferred Revenue
- - - - -

Cel AI Semi-Annual Data
Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only - - - - -

Cel AI Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Cel AI's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cel AI (LSE:CLAI) Business Description

Traded in Other Exchanges
Address
16 Great Queen Street, 9th Floor, London, GBR, WC2B 5DG
Cellular Goods PLC develops efficacy-led and research-backed cannabinoid products. The company is launching with two product brands covering distinct market segments: a face-mask and serum-containing synthetic CBD, and a topical athletic recovery gel roll-on product. These will be made available through partnerships with online and physical retailers and direct to consumers through the company's website.

Cel AI (LSE:CLAI) Headlines

No Headlines